A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1997
10/29/1997	CN1163610A Compounds and methods for treatment of cardiovascular, imflammatory and immune disorders
10/29/1997	CN1163609A Modified polyunsatuated fatty acids
10/29/1997	CN1163605A Novel amino acid derivatives with improved multi-drug resistance activity
10/29/1997	CN1163604A Substituted r-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors
10/29/1997	CN1163571A Compositions containing at least one glucocorticoid in combination with pulmonary surfactant for treatment of IRDS and ARDS
10/29/1997	CN1163570A Dermatotogical compositions containing benzoyl peroxide and compound reducing skin irritation
10/29/1997	CN1163569A Combination of prostacyclin withe strogen or progestin for prevention and treatment of atherosclerotic vascular disease including preeclampsia and for treatment of hypertension and for hormone..
10/29/1997	CN1163568A Use of 9-deoxy prostaglandin derivatives to treat glaucoma
10/29/1997	CN1163567A Method for minimizing uterotrophic effect of tamoxifen and tamoxifen analogues
10/29/1997	CN1163566A Quinazolinone pharmaceuticals and use thereof
10/29/1997	CN1163565A 5 alpha-reductase inhibitors
10/29/1997	CN1163563A Liposome composition containing selegilin
10/29/1997	CN1163401A Fully automatic hemacytometer reagent and preparing method
10/29/1997	CN1163270A Anti-hyerplasia and anti-inflammatory compound: pentose monosaccharide devivative
10/29/1997	CN1163268A Quinolinone derivatives and antianaphylactic agent containing said quinolinone devivative as biological active component
10/29/1997	CN1163267A Fluoroalkyl-and-fluoroalkoxyl substituted heterocyclo bradykinin antagonist and its preparing method and use
10/29/1997	CN1163266A 2-aryl substituted pyridine compound
10/29/1997	CN1163263A Substituted diaryl dicarboxylic diguanidine, and its preparing method, use as medicine or diagnostic reagent and medicine containing it
10/29/1997	CN1163142A Medicine for curing peptic ulcer
10/29/1997	CN1163137A Soft extract for curing scald
10/29/1997	CN1163122A Seabuckthorn fruit yolk health oil and its producing method
10/29/1997	CN1163106A High efficiency anti-inflammatory and antipruritic ointment and its producing method
10/29/1997	CN1163105A Therapy and prevention for esteoporosis
10/29/1997	CN1163104A Medicinal preparation containing shikimic acid and its derivatives, and its use in preparing anti-thrombosis and analgesic medicine
10/29/1997	CN1163103A Controlled releasing of steroid from sugarcoating
10/29/1997	CN1036267C Method for preparing amino-substituted benzoyl guanidines
10/29/1997	CN1036265C Preparation of heterocyclic compounds
10/29/1997	CN1036263C Preparation of substituted azole
10/28/1997	US5681965 Alpha-phenyl tert-butyl nitrone and derivatives as free radical scavengers treating aging, oxidative tissue damage
10/28/1997	US5681961 Arylsulphonamides, pharmaceutical compositions containing these compounds and processes for preparing them
10/28/1997	US5681958 Cryptolepine analogs with hypoglycemic activity
10/28/1997	US5681956 Useful in diagnosis and treatment of schizophrenia and depression as well as parkinsonism
10/28/1997	US5681955 Photostability of polymers
10/28/1997	US5681944 Hybridizes with the translation initiation region of the e6 or e7 messanger rna of human papilloma virus such that replication of virus is inhibited
10/28/1997	US5681941 Substituted purines and oligonucleotide cross-linking
10/28/1997	US5681940 Sugar modified nucleosides and oligonucleotides
10/28/1997	US5681864 Composition for external skin care
10/28/1997	US5681863 Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors
10/28/1997	US5681862 Ionene polymers as microbicides
10/28/1997	US5681861 Aminoguanidines and methods of use of same
10/28/1997	US5681860 Method of increasing expression of HLA, cell surface and TAA antigens of cells using 3-(N-acetylamino)-5-(N-decyl-N-methylamino)-benzyl alcohol
10/28/1997	US5681859 Insecticide and insect repellant compositions
10/28/1997	US5681858 Cycloalkyl hydroxyureas
10/28/1997	US5681857 Alkaline salt solutions for treating cancerous tumors
10/28/1997	US5681855 Prostaglandin e emulsion
10/28/1997	US5681854 Use of aliphatic carboxylic acid derivatives in ophthalmic disorders
10/28/1997	US5681853 Mixture with amphoteric compound
10/28/1997	US5681852 Zwitterionic surfactant and sulfhydryl compound in cosmetically and/or pharmaceutically acceptable topical carrier
10/28/1997	US5681850 Method of treatment of impotence with prostaglandin E1 derivatives
10/28/1997	US5681849 Pharmaceutical composition for topical applications
10/28/1997	US5681848 Vision disorders
10/28/1997	US5681847 Administering anticarcinogenic lactone compounds
10/28/1997	US5681846 Extended stability formulations for paclitaxel
10/28/1997	US5681845 DMPO spin trapping compositions and methods of use thereof
10/28/1997	US5681841 Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
10/28/1997	US5681838 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation
10/28/1997	US5681837 Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
10/28/1997	US5681835 Useful for treating osteoporosis
10/28/1997	US5681833 Benzodiazepine derivatives
10/28/1997	US5681831 Method of treating viral and retroviral infections including HIV by administration of N6 -(Δ)2 -isopentenyl) adenosine or an analogue thereof
10/28/1997	US5681829 Class of phosphocholine derivatives having antifungal activity
10/28/1997	US5681827 Aqueous pourable liquid containing low viscosity sodium alginate, potassium bicarbonate
10/28/1997	US5681826 Includes a sugar alcohol and a non-reducing saccharide containing trehalose
10/28/1997	US5681825 Surgical method
10/28/1997	US5681824 Substituted liposaccharides useful in the treatment and prevention of endotoxemia
10/28/1997	US5681823 P1, P4 -dithio-P2 -P3 -monochloromethylene 5', 5'"-diadenosine P1, P4 -tetraphosphate as antithrombotic agent
10/28/1997	US5681822 Shelf stable solutions of cladribine in benzyl alcohol
10/28/1997	US5681812 Methods and compositions for reducing multidrug resistance
10/28/1997	US5681811 Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
10/28/1997	US5681747 Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof
10/28/1997	US5681724 Parasitic helminth macrophage inhibitory factor nucleic acid molecules and uses thereof
10/28/1997	US5681608 Nutrient fats having improved digestibility
10/28/1997	US5681590 Dry mix formulation for bisphosphonic acids
10/28/1997	US5681589 Anticancer agents
10/28/1997	US5681588 Delayed release microtablet of β-phenylpropiophenone derivatives
10/28/1997	US5681585 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
10/28/1997	US5681582 Extended release, film-coated tablet of astemizole and pseudoephedrine
10/28/1997	US5681578 Mixture containing 4-aminobutyric acid, glutamine, glycine, magnesium, passion flower, primula officinalis, vitamin b6 for aiding natural inhibitory neurotransmitter system of brain
10/28/1997	US5681577 Multiple action cold/sinus preparations
10/28/1997	US5681576 Method and composition for post surgical adhesion reduction
10/28/1997	US5681573 Dissolving in water saturated with carbon dioxide, then freeze drying the solution yields storage stable drug for injection after regeneration
10/28/1997	US5681565 Coating with immunoglobulins, antibodies
10/28/1997	US5681558 Method of using beta-interferons to treat restenosis
10/28/1997	US5681555 Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
10/28/1997	US5680962 Lotion which is temporarily colored upon application
10/28/1997	CA2136825C Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque
10/25/1997	CA2203466A1 Novel specific immunophilin ligands as antiasthmatics and immunosuppressants
10/25/1997	CA2199920A1 Acetylsalicylic acid-containing alcoholic solutions for percutaneous employment, their use for antithrombotic therapy, and a pharmaceutical
10/24/1997	CA2194428A1 Controlled release of steroids from sugar coatings
10/23/1997	WO1997039353A1 Oxidative metabolism in smooth muscle cells: methods and materials relating thereto
10/23/1997	WO1997039128A2 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
10/23/1997	WO1997039127A1 Hybrid interferon compositions and methods of use
10/23/1997	WO1997039126A1 Novel rantes homolog from prostate
10/23/1997	WO1997039120A2 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression
10/23/1997	WO1997039119A1 Mammalian genes involved in viral infection and tumor suppression
10/23/1997	WO1997039115A1 Immobilized alliinase and continuous production of allicin
10/23/1997	WO1997039111A1 Compositions containing bacteriophages and methods of using bacteriophages to treat infections
10/23/1997	WO1997039033A1 Purification of factor viii complex by immunoaffinity chromatography
10/23/1997	WO1997039031A1 Glucagon-like peptide-2 analogs
10/23/1997	WO1997039025A1 A cyclic hepta-peptide derivative from colonial ascidians, lissoclinum sp.

1 ... 6732 6733 6734 6735 6736 6737 6738 6739 6740 6741 6742 6743 6744 6745 6746 6747 6748 6749 6750 6751 6752 ... 7860